{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:10:06Z","timestamp":1789143006080,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_173222\/1"],"award-info":[{"award-number":["310030_173222\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["FP7-PEOPLE-2012-ITN project 316679 TRANSACT"],"award-info":[{"award-number":["FP7-PEOPLE-2012-ITN project 316679 TRANSACT"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006387","name":"Fondation Leenaards","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001706","name":"Louis-Jeantet Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006392","name":"Centre Hospitalier Universitaire Vaudois","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["NIH R01 award (DK082435) and VA Merit award (BX002638)"],"award-info":[{"award-number":["NIH R01 award (DK082435) and VA Merit award (BX002638)"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["VA Career Development award (BX003486)"],"award-info":[{"award-number":["VA Career Development award (BX003486)"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006388","name":"H\u00f4pitaux Universitaires de Gen\u00e8ve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006391","name":"Centre d'Imagerie BioM\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic liver disease leads to neuropsychiatric complications called hepatic encephalopathy (HE). Current treatments have some limitations in their efficacy and tolerability, emphasizing the need for alternative therapies. Modulation of gut bacterial flora using probiotics is emerging as a therapeutic alternative. However, knowledge about how probiotics influence brain metabolite changes during HE is missing. In the present study, we combined the advantages of ultra-high field in vivo <jats:sup>1<\/jats:sup>H MRS with behavioural tests to analyse whether a long-term treatment with a multistrain probiotic mixture (VIVOMIXX) in a rat model of type C HE had a positive effect on behaviour and neurometabolic changes. We showed that the prophylactic administration of this probiotic formulation led to an increase in gut <jats:italic>Bifidobacteria<\/jats:italic> and attenuated changes in locomotor activity and neurometabolic profile in a rat model of type C HE. Both the performance in behavioural tests and the neurometabolic profile of BDL\u2009+\u2009probiotic rats were improved compared to the BDL group at week 8 post-BDL. They displayed a significantly lesser increase in brain Gln, a milder decrease in brain mIns and a smaller decrease in neurotransmitter Glu than untreated animals. The clinical implications of these findings are potentially far-reaching given that probiotics are generally safe and well-tolerated by patients.<\/jats:p>","DOI":"10.1038\/s41598-021-81871-8","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T11:05:05Z","timestamp":1611659105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Veronika","family":"Rackayov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Braissant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Mastromarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"McMillin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"DeMorrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie A.","family":"McLin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cudalbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"81871_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11011-016-9938-3","volume":"32","author":"S Dasarathy","year":"2017","unstructured":"Dasarathy, S. et al. Ammonia toxicity: From head to toe?. Metab. Brain Dis. 32, 529\u2013538 (2017).","journal-title":"Metab. Brain Dis."},{"key":"81871_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11011-008-9124-3","volume":"24","author":"M Romero-G\u00f3mez","year":"2009","unstructured":"Romero-G\u00f3mez, M., Jover, M., Gal\u00e1n, J. J. & Ruiz, A. Gut ammonia production and its modulation. Metab. Brain Dis. 24, 147\u2013157 (2009).","journal-title":"Metab. Brain Dis."},{"key":"81871_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00134-017-4845-6","volume":"44","author":"N Weiss","year":"2018","unstructured":"Weiss, N., Jalan, R. & Thabut, D. Understanding hepatic encephalopathy. Intensive Care Med. 44, 231\u2013234 (2018).","journal-title":"Intensive Care Med."},{"key":"81871_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1365-2958.1993.tb01220.x","volume":"9","author":"CM Collins","year":"1993","unstructured":"Collins, C. M. & D\u2019Orazio, S. E. F. Bacterial ureases: Structure, regulation of expression and role in pathogenesis. Mol. Microbiol. 9, 907\u2013913 (1993).","journal-title":"Mol. Microbiol."},{"key":"81871_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4161\/gmic.28684","volume":"5","author":"JS Bajaj","year":"2014","unstructured":"Bajaj, J. S. The role of microbiota in hepatic encephalopathy. Gut Microbes 5, 397\u2013403 (2014).","journal-title":"Gut Microbes"},{"key":"81871_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3109\/00365528509091662","volume":"20","author":"BA Hansen","year":"1985","unstructured":"Hansen, B. A. & Vilstrup, H. Increased intestinal hydrolysis of urea in patients with alcoholic cirrhosis. Scand. J. Gastroenterol. 20, 346\u2013350 (1985).","journal-title":"Scand. J. Gastroenterol."},{"key":"81871_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hep.24423","volume":"54","author":"Y Chen","year":"2011","unstructured":"Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562\u2013572 (2011).","journal-title":"Hepatology"},{"key":"81871_CR8","doi-asserted-by":"publisher","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","volume":"302","author":"JS Bajaj","year":"2012","unstructured":"Bajaj, J. S. et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. AJP Gastrointest. Liver Physiol. 302, G168\u2013G175 (2012).","journal-title":"AJP Gastrointest. Liver Physiol."},{"key":"81871_CR9","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J. Hepatol. 60, 940\u2013947 (2014).","journal-title":"J. Hepatol."},{"key":"81871_CR10","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","volume":"65","author":"J Sabino","year":"2016","unstructured":"Sabino, J. et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut 65, 1681\u20131689 (2016).","journal-title":"Gut"},{"key":"81871_CR11","doi-asserted-by":"publisher","first-page":"26800","DOI":"10.1038\/srep26800","volume":"6","author":"V Ahluwalia","year":"2016","unstructured":"Ahluwalia, V. et al. Impaired gut-liver-brain axis in patients with cirrhosis. Sci. Rep. 6, 26800 (2016).","journal-title":"Sci. Rep."},{"key":"81871_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","volume":"58","author":"G Kakiyama","year":"2013","unstructured":"Kakiyama, G. et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J. Hepatol. 58, 949\u2013955 (2013).","journal-title":"J. Hepatol."},{"key":"81871_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1099\/00222615-42-2-102","volume":"42","author":"DM Delahooke","year":"1995","unstructured":"Delahooke, D. M., Barclay, G. R. & Poxton, I. R. A Reappraisal of the biological-activity of bacteroides Lps. J. Med. Microbiol. 42, 102\u2013112 (1995).","journal-title":"J. Med. Microbiol."},{"key":"81871_CR14","doi-asserted-by":"publisher","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","volume":"303","author":"JS Bajaj","year":"2012","unstructured":"Bajaj, J. S. et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. AJP Gastrointest. Liver Physiol. 303, G675\u2013G685 (2012).","journal-title":"AJP Gastrointest. Liver Physiol."},{"key":"81871_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jcmgh.2015.04.003","volume":"1","author":"C Llorente","year":"2015","unstructured":"Llorente, C. & Schnabl, B. The gut microbiota and liver disease. Cell. Mol. Gastroenterol. Hepatol. 1, 275\u2013284 (2015).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"81871_CR16","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/0016-5085(95)90147-7","volume":"108","author":"G Garcia-Tsao","year":"1995","unstructured":"Garcia-Tsao, G. et al. Bacterial translocation to mesenteric lymph-nodes is increased in cirrhotic rats with ascites. Gastroenterology 108, 1835\u20131841 (1995).","journal-title":"Gastroenterology"},{"key":"81871_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3748\/wjg.v5.i5.391","volume":"5","author":"O Saitoh","year":"1999","unstructured":"Saitoh, O. et al. Increased prevalence of intestinal inflammation in patients with liver cirrhosis. World J. Gastroenterol. 5, 391\u2013396 (1999).","journal-title":"World J. Gastroenterol."},{"key":"81871_CR18","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jhep.2013.01.038","volume":"58","author":"J Du Plessis","year":"2013","unstructured":"Du Plessis, J. et al. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J. Hepatol. 58, 1125\u20131132 (2013).","journal-title":"J. Hepatol."},{"key":"81871_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest, R., Lawson, M. & Geuking, M. Pathological bacterial translocation in liver cirrhosis. J. Hepatol. 60, 197\u2013209 (2014).","journal-title":"J. Hepatol."},{"key":"81871_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jhep.2014.06.004","volume":"61","author":"R Wiest","year":"2014","unstructured":"Wiest, R., Lawson, M. & Geuking, M. Reply to: \u2018Bacterial translocation in liver cirrhosis: Site and role in fibrogenesis\u2019. J. Hepatol. 61, 710\u2013711 (2014).","journal-title":"J. Hepatol."},{"key":"81871_CR21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s11011-015-9743-4","volume":"31","author":"VC Patel","year":"2016","unstructured":"Patel, V. C., White, H., St\u00f8y, S., Bajaj, J. S. & Shawcross, D. L. Clinical science workshop: Targeting the gut-liver-brain axis. Metab. Brain Dis. 31, 1327\u20131337 (2016).","journal-title":"Metab. Brain Dis."},{"key":"81871_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cgh.2010.06.024","volume":"8","author":"M Merli","year":"2010","unstructured":"Merli, M. et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin. Gastroenterol. Hepatol. 8, 979-985.e1 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"81871_CR23","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jhep.2012.11.023","volume":"58","author":"EMM Quigley","year":"2013","unstructured":"Quigley, E. M. M., Stanton, C. & Murphy, E. F. The gut microbiota and the liver. Pathophysiological and clinical implications. J. Hepatol. 58, 1020\u20131027 (2013).","journal-title":"J. Hepatol."},{"key":"81871_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.2165\/00003495-199753060-00003","volume":"53","author":"MR Clausen","year":"1997","unstructured":"Clausen, M. R. & Mortensen, P. B. Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 53, 930\u2013942 (1997).","journal-title":"Drugs"},{"key":"81871_CR25","first-page":"20","volume":"8","author":"JS Bajaj","year":"2013","unstructured":"Bajaj, J. S. et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS ONE 8, 20 (2013).","journal-title":"PLoS ONE"},{"key":"81871_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajg.2013.08.002","volume":"14","author":"DH Ziada","year":"2013","unstructured":"Ziada, D. H., Soliman, H. H., El Yamany, S. A., Hamisa, M. F. & Hasan, A. M. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy. Arab. J. Gastroenterol. 14, 116\u2013122 (2013).","journal-title":"Arab. J. Gastroenterol."},{"key":"81871_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1365-2036.2010.04574.x","volume":"33","author":"S Shukla","year":"2011","unstructured":"Shukla, S., Shukla, A., Mehboob, S. & Guha, S. Meta-analysis: The effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment. Pharmacol. Ther. 33, 662\u2013671 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"81871_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4161\/gmic.1.6.13610","volume":"1","author":"I Rowland","year":"2010","unstructured":"Rowland, I. et al. Current level of consensus on probiotic science-report of an expert meeting\u2014London, 23 November 2009. Gut Microbes 1, 436\u2013439 (2010).","journal-title":"Gut Microbes"},{"key":"81871_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12429","author":"V Pratap Mouli","year":"2014","unstructured":"Pratap Mouli, V. et al. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial. Hepatol. Res. https:\/\/doi.org\/10.1111\/hepr.12429 (2014).","journal-title":"Hepatol. Res."},{"key":"81871_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/MEG.0b013e3282f3e6f5","volume":"20","author":"P Sharma","year":"2008","unstructured":"Sharma, P., Sharma, B. C., Puri, V. & Sarin, S. K. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur. J. Gastroenterol. Hepatol. 20, 20 (2008).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"81871_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nut.2010.01.006","volume":"27","author":"D Pereg","year":"2011","unstructured":"Pereg, D. et al. Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study. Nutrition 27, 177\u2013181 (2011).","journal-title":"Nutrition"},{"key":"81871_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/gmic.2.2.15416","volume":"2","author":"GM Nava","year":"2011","unstructured":"Nava, G. M. & Stappenbeck, T. S. Diversity of the autochthonous colonic microbiota. Gut Microbes 2, 20 (2011).","journal-title":"Gut Microbes"},{"key":"81871_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/MEG.0b013e32834696f5","volume":"23","author":"VV Mittal","year":"2011","unstructured":"Mittal, V. V., Sharma, B. C., Sharma, P. & Sarin, S. K. A randomized controlled trial comparing lactulose, probiotics, and l-ornithine l-aspartate in treatment of minimal hepatic encephalopathy. Eur. J. Gastroenterol. Hepatol. 23, 725\u2013732 (2011).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"81871_CR34","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.cgh.2013.11.006","volume":"12","author":"MK Lunia","year":"2014","unstructured":"Lunia, M. K., Sharma, B. C., Sharma, P., Sachdeva, S. & Srivastava, S. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: A randomized controlled trial. Clin. Gastroenterol. Hepatol. 12, 1003-1008.e1 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"81871_CR35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hep4.1325","volume":"3","author":"E Rom\u00e1n","year":"2019","unstructured":"Rom\u00e1n, E. et al. Effect of a multistrain probiotic on cognitive function and risk of falls in patients with cirrhosis: A randomized trial. Hepatol. Commun. 3, 632\u2013645 (2019).","journal-title":"Hepatol. Commun."},{"key":"81871_CR36","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/liv.13005","volume":"36","author":"S Saab","year":"2016","unstructured":"Saab, S. et al. Probiotics are helpful in hepatic encephalopathy: A meta-analysis of randomized trials. Liver Int. 36, 986\u2013993 (2016).","journal-title":"Liver Int."},{"key":"81871_CR37","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/apt.12661","volume":"39","author":"X Ding","year":"2014","unstructured":"Ding, X., Zhang, F. & Wang, Y. Letter: Probiotics vs lactulose for minimal hepatic encephalopathy therapy. Aliment. Pharmacol. Ther. 39, 1000 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"81871_CR38","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/hepr.12429","volume":"45","author":"V Pratap Mouli","year":"2015","unstructured":"Pratap Mouli, V. et al. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial. Hepatol. Res. 45, 880\u2013889 (2015).","journal-title":"Hepatol. Res."},{"key":"81871_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-013-9452-9","author":"L Chavarria","year":"2013","unstructured":"Chavarria, L. & Cordoba, J. Magnetic resonance of the brain in chronic and acute liver failure. Metab. Brain Dis. https:\/\/doi.org\/10.1007\/s11011-013-9452-9 (2013).","journal-title":"Metab. Brain Dis."},{"key":"81871_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.abb.2013.05.006","volume":"536","author":"S Keiding","year":"2013","unstructured":"Keiding, S. & Pavese, N. Brain metabolism in patients with hepatic encephalopathy studied by PET and MR. Arch. Biochem. Biophys. 536, 131\u2013142 (2013).","journal-title":"Arch. Biochem. Biophys."},{"key":"81871_CR41","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.3748\/wjg.v12.i19.2969","volume":"12","author":"V-PB Grover","year":"2006","unstructured":"Grover, V.-P.B. et al. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J. Gastroenterol. 12, 2969\u20132978 (2006).","journal-title":"World J. Gastroenterol."},{"key":"81871_CR42","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s11011-015-9715-8","volume":"31","author":"V Rackayova","year":"2016","unstructured":"Rackayova, V. et al. 1H and 31P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: In vivo longitudinal measurements of brain energy metabolism. Metab. Brain Dis. 31, 1303\u20131314 (2016).","journal-title":"Metab. Brain Dis."},{"key":"81871_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jhep.2019.05.022","volume":"71","author":"O Braissant","year":"2019","unstructured":"Braissant, O. et al. Longitudinal neurometabolic changes in the hippocampus of a rat model of chronic hepatic encephalopathy. J. Hepatol. 71, 505\u2013515 (2019).","journal-title":"J. Hepatol."},{"key":"81871_CR44","doi-asserted-by":"publisher","first-page":"10821","DOI":"10.1523\/JNEUROSCI.0575-15.2015","volume":"35","author":"C D\u2019Mello","year":"2015","unstructured":"D\u2019Mello, C. et al. Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J. Neurosci. 35, 10821\u201310830 (2015).","journal-title":"J. Neurosci."},{"key":"81871_CR45","doi-asserted-by":"publisher","first-page":"702","DOI":"10.20960\/nh.626","volume":"34","author":"TO Hammes","year":"2017","unstructured":"Hammes, T. O. et al. Lactobacillus rhamnosusGG reduces hepatic fibrosis in a model of chronic liver disease in rats. Nutr. Hosp. 34, 702\u2013709 (2017).","journal-title":"Nutr. Hosp."},{"key":"81871_CR46","first-page":"20","volume":"2017","author":"R Dalal","year":"2017","unstructured":"Dalal, R., McGee, R. G., Riordan, S. M. & Webster, A. C. Probiotics for people with hepatic encephalopathy. Cochrane Database Syst. Rev 2017, 20 (2017).","journal-title":"Cochrane Database Syst. Rev"},{"key":"81871_CR47","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1478-3231.2009.02034.x","volume":"29","author":"RF Butterworth","year":"2009","unstructured":"Butterworth, R. F. et al. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int. 29, 783\u2013788 (2009).","journal-title":"Liver Int."},{"key":"81871_CR48","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10534-014-9762-3","volume":"27","author":"P Mastromarino","year":"2014","unstructured":"Mastromarino, P. et al. Correlation between lactoferrin and beneficial microbiota in breast milk and infant\u2019s feces. Biometals 27, 1077\u20131086 (2014).","journal-title":"Biometals"},{"key":"81871_CR49","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/mrm.21043","volume":"56","author":"V Mlyn\u00e1rik","year":"2006","unstructured":"Mlyn\u00e1rik, V., Gambarota, G., Frenkel, H. & Gruetter, R. Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition. Magn. Reson. Med. 56, 965\u2013970 (2006).","journal-title":"Magn. Reson. Med."},{"key":"81871_CR50","first-page":"213","volume":"97","author":"F Bahceci","year":"2005","unstructured":"Bahceci, F., Yildirim, B., Karincaoglu, M., Dogan, I. & Sipahi, B. Memory impairment in patients with cirrhosis. J. Natl. Med. Assoc. 97, 213\u2013216 (2005).","journal-title":"J. Natl. Med. Assoc."},{"key":"81871_CR51","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1128\/AEM.67.9.4111-4118.2001","volume":"67","author":"J Dabard","year":"2001","unstructured":"Dabard, J. et al. Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavu s strain isolated from human feces. Appl. Environ. Microbiol. 67, 4111\u20134118 (2001).","journal-title":"Appl. Environ. Microbiol."},{"key":"81871_CR52","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","volume":"48","author":"V Stadlbauer","year":"2008","unstructured":"Stadlbauer, V. et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J. Hepatol. 48, 945\u2013951 (2008).","journal-title":"J. Hepatol."},{"key":"81871_CR53","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","volume":"147","author":"RK Dhiman","year":"2014","unstructured":"Dhiman, R. K. et al. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: A randomized, controlled trial. Gastroenterology 147, 1327-1337.e3 (2014).","journal-title":"Gastroenterology"},{"key":"81871_CR54","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/apt.12661","volume":"39","author":"X Ding","year":"2014","unstructured":"Ding, X., Zhang, F. & Wang, Y. Letter: Probiotics vs lactulose for minimal hepatic encephalopathy therapy. Alimentary Pharmacol. Therap. 39, 1000 (2014).","journal-title":"Alimentary Pharmacol. Therap."},{"key":"81871_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008716.pub2","author":"RG McGee","year":"2011","unstructured":"McGee, R. G., Bakens, A., Wiley, K., Riordan, S. M. & Webster, A. C. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD008716.pub2 (2011).","journal-title":"Cochrane Database Syst. Rev."},{"key":"81871_CR56","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0168-8278(01)00181-7","volume":"35","author":"J C\u00f3rdoba","year":"2001","unstructured":"C\u00f3rdoba, J. et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J. Hepatol. 35, 598\u2013604 (2001).","journal-title":"J. Hepatol."},{"key":"81871_CR57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nrn3587","volume":"14","author":"V Felipo","year":"2013","unstructured":"Felipo, V. Hepatic encephalopathy: Effects of liver failure on brain function. Nat. Rev. Neurosci. 14, 851\u2013858 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"81871_CR58","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s11011-016-9906-y","volume":"31","author":"L Baker","year":"2016","unstructured":"Baker, L. et al. New technologies\u2014new insights into the pathogenesis of hepatic encephalopathy. Metab. Brain Dis. 31, 1259\u20131267 (2016).","journal-title":"Metab. Brain Dis."},{"key":"81871_CR59","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1872-034X.2012.01015.x","volume":"42","author":"K Holte","year":"2012","unstructured":"Holte, K., Krag, A. & Gluud, L. L. Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy. Hepatol. Res. 42, 1008\u20131015 (2012).","journal-title":"Hepatol. Res."},{"key":"81871_CR60","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/apt.12695","volume":"39","author":"JS Bajaj","year":"2014","unstructured":"Bajaj, J. S. et al. Randomized clinical trial: Lactobacillus gg modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol. Ther. 39, 1113\u20131125 (2014).","journal-title":"Aliment Pharmacol. Ther."},{"key":"81871_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-016-9826-x","author":"BC Sharma","year":"2016","unstructured":"Sharma, B. C. & Singh, J. Probiotics in management of hepatic encephalopathy. Metab. Brain Dis. https:\/\/doi.org\/10.1007\/s11011-016-9826-x (2016).","journal-title":"Metab. Brain Dis."},{"key":"81871_CR62","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.cgh.2015.06.039","volume":"13","author":"KR Patidar","year":"2015","unstructured":"Patidar, K. R. & Bajaj, J. S. Covert and overt hepatic encephalopathy: Diagnosis and management. Clin. Gastroenterol. Hepatol. 13, 2048\u20132061 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81871-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81871-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81871-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:31:47Z","timestamp":1670034707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81871-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["81871"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-81871-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2269"}}